Journal of Cellular Biochemistry

Cover image for Journal of Cellular Biochemistry

Supplement: Chemoprevention of Premalignant Lesions of the Upper Aerodigestive Tract

1993

Volume 53, Issue S17F

Pages fmi–fmi, 1–300

  1. Masthead

    1. Top of page
    2. Masthead
    3. Articles
    1. Masthead (page fmi)

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531001

  2. Articles

    1. Top of page
    2. Masthead
    3. Articles
    1. Foreword (page 1)

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531002

    2. Development of chemopreventive agents for lung and upper aerodigestive tract cancers (pages 2–17)

      Gary J. Kelloff, Charles W. Boone, Vernon K. Steele, Marjorie Perloff, James Crowell and Linda A. Doody

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531003

    3. Carcinogen biomarkers related to smoking and upper aerodigestive tract cancer (pages 27–35)

      Stephen S. Hecht, Steven G. Carmella, Sharon E. Murphy, Peter G. Foiles and Fung-Lung Chung

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531005

    4. Premalignant lesions in the upper aerodigestive tract (page 36)

      Charles W. Boone

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531006

    5. Intraepithelial neoplasia, surrogate endpoint biomarkers, and cancer chemoprevention (pages 37–48)

      Dr. Charles W. Boone and Gary J. Kelloff

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531007

    6. Premalignant lesions of the upper aerodigestive tract: Pathologic classification (pages 49–56)

      John D. Crissman, Daniel W. Visscher and Wael Sakr

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531008

    7. Early lung cancer as a potential target for chemoprevention (pages 57–65)

      Myron R. Melamed and Betty J. Flehinger

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531009

    8. Cytologic diagnosis of oral, esophageal, and peripheral lung cancer (pages 66–81)

      Leopold G. Koss

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531010

    9. Animal models (page 82)

      Richard C. Moon

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531011

    10. The hamster cheek pouch carcinogenesis model (pages 83–90)

      Dr. Irma B. Gimenez-Conti and Thomas J. Slaga

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531012

    11. Esophageal carcinogenesis in the rat: A model for aerodigestive tract cancer (pages 91–94)

      Michael J. Wargovich and Osamu Imada

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531013

    12. Lung tumors in strain a mice: Application for studies in cancer chemoprevention (pages 95–103)

      Gary D. Stoner, Gabriela Adam-Rodwell and Mark A. Morse

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531014

    13. Molecular epidemiology of lung cancer and the modulation of markers of chronic carcinogen exposure by chemopreventive agents (pages 119–128)

      Dr. Frederica P. Perera, Deliang Tang, Ricardo A. Grinberg-Funes, M. Anne Blackwood, Christopher Dickey, William Blaner and Regina M. Santella

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531017

    14. Metabolic activation, DNA adducts, and H-ras mutations in human neoplastic and non-neoplastic laryngeal tissue (pages 129–137)

      Scott J. Stern, Masakuni Degawa, Martha V. Martin, F. Peter Guengerich, R. Keith Kaderlik, Kenneth F. Ilett, Randall Breau, Michael McGhee, Donna Montague, Beverly Lyn-Cook and Fred F. Kadlubar

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531018

    15. DNA adducts in model systems and humans (pages 138–148)

      Kenneth W. Turteltaub, Chris E. Frantz, Moire R. Creek, John S. Vogel, Nancy Shen and Esther Fultz

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531019

    16. Viruses (page 149)

      Leslie Brand

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531020

    17. Epstein-Barr virus and nasopharyngeal carcinoma (pages 150–154)

      Dr. Gary R. Pearson

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531021

    18. Papillomaviruses in head and neck disease: Pathophysiology and possible regulation (pages 155–164)

      Dr. Bettie M. Steiberg and Karen J. Auborn

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531022

    19. Intermediate biomarkers (pages 165–166)

      Reuben Lotan

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531023

    20. Prospective trial evaluating immunocytochemical-based sputum techniques for early lung cancer detection: Assays for promotion factors in the bronchial lavage (pages 175–183)

      Frank Scott, Frank Cuttitta, Anthony M. Treston, Ingalill Avis, Prabodh Gupta, John Ruckdeschel, Karen Kelly, Steven Piantadosi, Melvyn Tockman and James Mulshine

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531025

    21. Oncogene mutations as intermediate markers (pages 184–187)

      David Sidransky, Jay Boyle, Wayne Koch and Peter van der Riet

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531026

    22. TGF-α and EGFR in head and neck cancer (pages 188–191)

      Jennifer R. Grandis and David J. Tweardy

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531027

    23. Premalignant lesions of the upper aerodigestive tract: Biomarkers of genetic alterations, proliferation, and differentiation (pages 192–198)

      John D. Crissman, Daniel W. Visscher and Fazlul H. Sarkar

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531028

    24. Tissue autofluorescence as an intermediate endpoint in cancer chemoprevention trials (pages 199–204)

      Stimson P. Schantz and Robert R. Alfano

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531029

    25. Genetic biomarkers (page 205)

      Ugo Pastorino

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531030

    26. Clinical experience with the micronucleus assay (pages 206–212)

      Dr. Harinder S. Garewal, Lois Ramsey, George Kaugars and Jay Boyle

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531031

    27. Chromosomal biomarkers in the clonal evolution of head and neck squamous neoplasia (pages 213–222)

      Dr. Thomas E. Carey, Maria J. Worsham and Daniel L. Van Dyke

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531032

    28. Blood group antigens and integrins as biomarkers in head and neck cancer: Is aberrant tyrosine phosphorylation the cause of altered α6β4 integrin expression? (pages 223–232)

      Dr. Thomas E. Carey, Thankam S. Nair, Catherine Chern, Monica Liebert, H. Barton Grossman, Gregory T. Wolf and Carter Van Waes

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531033

    29. Early genetic changes during upper aerodigestive tract tumorigenesis (pages 233–236)

      Dr. Walter N. Hittelman, Narin Voravud, Dong M. Shin, Jin Soo Lee, Jae Y. Ro and Waun Ki Hong

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531034

    30. Genetic changes in lung cancer (pages 237–248)

      Ugo Pastorino, Gabriella Sozzi, Monica Miozzo, Elda Tagliabue, Silvana Pilotti and Marco A. Pierotti

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531035

    31. Candidate chemoprevention agents in clinical trials (page 249)

      Waun Ki Hong

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531036

    32. Micronuclei: A potential intermediate marker for chemoprevention of aerodigestive tract cancer (pages 250–254)

      Dr. Steven E. Benner, Michael J. Wargovich, Scott M. Lippman and Waun K. Hong

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531037

    33. Fenretinide (4-HPR) in chemoprevention of oral leukoplakia (pages 255–261)

      Fausto Chiesa, Nicoletta Tradati, Marino Marazza, Nicoletta Rossi, Patrizia Boracchi, Luigi Mariani, Franca Formelli, Roberto Giardini, Alberto Costa, Giuseppe De Palo and Umberto Veronesi

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531038

    34. Beta-carotene and vitamin E in oral cancer prevention (pages 262–269)

      Dr. Harinder S. Garewal

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531039

    35. N-acetyl-l-cysteine (pages 270–277)

      Dr. Nico De Vries and Silvio De Flora

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531040

    36. Oltipraz: A laboratory and clinical review (pages 278–291)

      Al B. Benson III

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531041

    37. A review of the use of antioxidant supplements in the treatment of human oral leukoplakia (pages 292–298)

      Dr. George E. Kaugars, Sol Silverman Jr., John G. L. Lovas, Richard B. Brandt, Joan S. Thompson and Vishwa N. Singh

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531042

    38. Strategy for design of clinical trials of chemopreventive agents (pages 299–300)

      Stimson P. Schantz, Waun Ki Hong, Charles W. Boone and Gary J. Kelioff

      Article first published online: 19 FEB 2004 | DOI: 10.1002/jcb.240531043

SEARCH

SEARCH BY CITATION